Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Price Movement Clarification

Beta Drugs Price Movement Clarification

Beta Drugs Ltd clarified to the exchange that no undisclosed price-sensitive information caused the recent price movement. The share price change is purely market-driven.

Source

NSE filing, NSE: BETA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Beta Drugs Ltd: key numbers

Share price
₹1,976.80
Market cap
₹2,191 Cr
Revenue (annual)
₹384.8 Cr
Net profit (annual)
₹41.48 Cr
P/E (TTM)
42.2×Sector 46.1×
Promoter holding
58.91%-0.19% QoQ
FII holding
1.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Beta Drugs Ltd

All →

Other price movement clarification announcements

All →